cetpinhibition.org

HDL biology

13-cis-retinoic acid strongly activates CETP through its negatively charged carboxylic group (Eur J Biochem 1996)

Original title: Modulation of the activity of the human cholesteryl ester transfer protein by carboxylated derivatives. Evidence for 13-cis-retinoic acid as a potent activator of the protein's activity in plasma

Eur J Biochem · · 7

Florentin E, Athias A, Lagrost L

The effects of palmitic acid, 13-cis-retinoic acid, all-trans-retinoic acid, and all-trans-retinol on human CETP activity were tested in both total plasma and reconstituted mixtures of purified CETP with isolated lipoproteins. In reconstituted mixtures, all carboxylated derivatives progressively increased cholesteryl ester transfer from HDL3 to LDL across a 20-100 microM range, while all-trans-retinol had minimal effect; 13-cis-retinoic acid was significantly more potent than the other derivatives at 60, 80, and 100 microM (P < 0.01). In total human plasma, however, only 13-cis-retinoic acid, not palmitic acid, produced significant concentration-dependent CETP stimulation, a difference traced to their differing affinities for albumin and lipoproteins, with fatty acid-poor albumin reducing CETP activity more for palmitic acid than for 13-cis-retinoic acid (P < 0.01). Cholesteryl ester transfer rates correlated strongly with the electrophoretic mobility of LDL (r = 0.98, P < 0.0002) and HDL (r = 0.96, P < 0.0008), supporting a key role for the carboxylic group of 13-cis-retinoic acid in upregulating CETP activity in both reconstituted and whole-plasma systems.

Read the paper (DOI)PubMed

Original abstract

The influence of palmitic acid, 13-cis-retinoic acid, all-trans-retinoic acid, and all-trans-retinol on the activity of the human cholesteryl ester transfer protein (CETP) was evaluated either in total human plasma supplemented with a tracer dose of 3H-labeled cholesteryl-ester-containing high-density lipoprotein sub-fraction 3 ([3H]CE-HDL3), or in reconstituted mixtures containing [3H]CE-HDL3, isolated low-density lipoproteins (LDL), and purified CETP. In reconstituted mixtures, all the carboxylated derivatives increased progressively and significantly the transfer of 3H-labeled cholesteryl esters from [3H]CE-HDL3 towards LDL in the 20-100 microM concentration range. Under identical experimental conditions, CETP activity was only minimally modified in the presence of all-trans-retinol. When present at a concentration of 60, 80, or 100 microM, 13-cis-retinoic acid was a significantly more potent activator of CETP activity than all the other derivatives studied (P < 0.01 in all cases). In contrast to observations made with reconstituted mixtures, only 13-cis-retinoic acid, but not palmitic acid, was able to induce a significant, concentration-dependent stimulation of CETP activity in total human plasma. In fact, differences in the ability of 13-cis-retinoic acid and palmitic acid to modulate the plasma cholesteryl ester transfer reaction were linked to their relative affinity for albumin and lipoprotein substrates: fatty-acid-poor albumin reduced CETP activity to a significantly greater extent in reconstituted mixtures containing palmitic acid than in reconstituted mixtures containing 13-cis-retinoic acid (P < 0.01 for all the incubation mixtures in the 1-10 g/l albumin concentration range); palmitic acid presented a markedly lower ability to increase the electrophoretic mobility of LDL and HDL fractions in total plasma than 13-cis-retinoic acid. In support of a key role of the negatively charged carboxylic group of 13-cis-retinoic acid in upregulating CETP activity, cholesteryl ester transfer rates correlated positively with the electrophoretic mobility of LDL (r = 0.98; P < 0.0002) and HDL (r = 0.96; P < 0.0008) in total plasma supplemented with the carboxylated compound. It is concluded that 13-cis-retinoic acid can upregulate the CETP-mediated cholesteryl ester transfer reaction both in reconstituted mixtures containing isolated lipoproteins and purified CETP, and in total normolipidemic human plasma.

HDL biologymechanisms

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.